Researchers: Comorbidities raise MERS mortality risks

07/26/2013 | Medscape (free registration)

Middle East respiratory syndrome is clinically different than severe acute respiratory syndrome and can lead to significant mortality rates in hospital patients who have comorbidities, according to a study in the Lancet Infectious Diseases. Researchers from Saudi Arabia said MERS can progress to respiratory failure five days earlier than SARS, although SARS appears to be more infectious in health care settings.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX